Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Rande Is who wrote (4599)	3/25/1999 2:32:00 PM
From: Bucky Katt	Read Replies (2) \| Respond to of 57584

I'm telling you guys, get on DYNT. When they talk about this thing on Opra, this thing will just fly...>>FDA Clears Cellulite Claims for Dynatronics' Synergie Device SALT LAKE CITY, March 25 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT - news) today announced that the United States Food and Drug Administration (FDA) has given formal clearance to expand labeling claims for the company's Synergie AMS device to include the claim of ''temporary reduction in the appearance of cellulite.'' ''After working with the FDA for seven months,'' said Kelvyn H. Cullimore, Jr., President of Dynatronics, ''we can now actively promote the Synergie AMS device for one of its most effective uses: reducing the appearance of cellulite. This claim is strongly supported by our research study, which revealed that 91 percent of the participants reported a favorable reduction in the appearance of cellulite.'' This is a multi-billion $$ market....